Expression of tissue plasminogen activator during eye development

被引:7
作者
Collinge, JE [1 ]
Simirskii, VN [1 ]
Duncan, MK [1 ]
机构
[1] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA
关键词
apical secretion; protease; lens; retina; optic vesicle; lens vesicle; fiber cell; epithelial cell; neuron;
D O I
10.1016/j.exer.2005.01.014
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Tissue plasminogen activator (tPA) is a serine protease responsible for the activation of plasminogen to plasmin as well as extracellular matrix remodeling. While tPA is used clinically to treat some retinal disorders and it is expressed at low levels in the adult eye, its expression pattern during eye development had never been determined. tPA protein is broadly dispersed in the lens placode and optic vesicle of the mouse eye and it becomes highly localized to the apical surfaces of both the lens pit and the optic cup as they invaginate. In the lens, tPA remains at the apical tips of both lens epithelial and fiber cells from the lens vesicle stage until birth in the mouse, when it begins to downregulate to barely detectable levels in adults. In humans, tPA is found in a similar pattern in the lens vesicle and early lens, however, appreciable protein is also detected in the cytoplasm of lens epithelial cells until adulthood. In the retina, tPA is found at the apical interface between the developing retinal pigmented epithelium and neural retina, then begins to downregulate once the photoreceptors have differentiated. In conclusion, tPA protein is found in a different pattern in embryonic versus adult eyes and may be involved in remodeling of the extracellular environment during eye development. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:90 / 96
页数:7
相关论文
共 31 条
[1]   A MOLECULAR VIEW OF VERTEBRATE RETINAL DEVELOPMENT [J].
BARNSTABLE, CJ .
MOLECULAR NEUROBIOLOGY, 1987, 1 (1-2) :9-46
[2]  
BENNETT B, 1990, BLOOD, V75, P671
[3]   THE VISUAL CYCLE OPERATES VIA AN ISOMERASE ACTING ON ALL-TRANS RETINOL IN THE PIGMENT-EPITHELIUM [J].
BRIDGES, CD ;
ALVAREZ, RA .
SCIENCE, 1987, 236 (4809) :1678-1680
[4]  
Coombs GS, 1996, J BIOL CHEM, V271, P4461
[5]  
Cottam DW, 1996, J CELL BIOCHEM, V60, P148, DOI 10.1002/(SICI)1097-4644(19960101)60:1<148::AID-JCB17>3.0.CO
[6]  
2-L
[7]   PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER [J].
DANO, K ;
ANDREASEN, PA ;
GRONDAHLHANSEN, J ;
KRISTENSEN, P ;
NIELSEN, LS ;
SKRIVER, L .
ADVANCES IN CANCER RESEARCH, 1985, 44 :139-266
[8]  
FINLAY BL, 1989, DEV VERTEBRATE RETIN
[9]  
GAUSSEM P, 1993, J BIOL CHEM, V268, P12150
[10]   Intravitreal tissue plasminogen activator in the management of central retinal vein occlusion [J].
Ghazi, NG ;
Noureddine, BN ;
Haddad, RS ;
Jurdi, FA ;
Bashshur, ZF .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2003, 23 (06) :780-784